The inhibitory effect of tranexamic acid on human ovarian carcinoma cell grown in vitro and in vivo
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 24 (2) , 183-188
- https://doi.org/10.1016/0090-8258(86)90026-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Studies on the mechanism of the antifibrinolytic action of tranexamic acidBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Tumor growth inhibition mediated by trypsin inhibitor or urokinase inhibitorsPublished by Elsevier ,1978
- Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue cultureNature, 1976
- Effect of proteolytic inhibitors on growth and surface architecture of normal and transformed cellsExperimental Cell Research, 1974
- PROPERTIES OF PLASMINOGEN ACTIVATORS FORMED BY NEOPLASTIC HUMAN CELL CULTURESThe Journal of Experimental Medicine, 1974
- Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: The plasminogen activator from SV-40-transformed hamster cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1974
- Selective Inhibition of Growth of Transformed Cells by Protease InhibitorsProceedings of the National Academy of Sciences, 1972
- Release of fibrinolytic activators from human tumours cultured in vitroCellular and Molecular Life Sciences, 1972
- Fibrin Degradation Products and Ovarian TumoursBMJ, 1971
- Plasminogen-activator-producing TumourBMJ, 1969